DCT

1:20-cv-00650

Celltech R&D Ltd v. Nektar Therapeutics

General
Filed
05/15/20
Cause of ActionPatent Infringement
SectorChemical
StatusClosed
Patent Owner
Operating Company
Nature of Suit830 Patent
Judge
Period
PO Win Rate
--
40%